Back to Search
GREGORY PELTON, M.D.
M.D.
Psychiatry Physician
NPI: 1598892077Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
207365(NY)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (19)
Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.
PMID 30037778·Am J Geriatr Psychiatry·2018
4-observational
Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.
PMID 24315979·Contemp Clin Trials·2014
2-rct
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
PMID 18088076·Int J Geriatr Psychiatry·2008
2-rct
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease.
PMID 19319929·Int J Geriatr Psychiatry·2009
8-other
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.
PMID 18723162·Biol Psychiatry·2008
8-other
Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.
PMID 18632806·J Nucl Med·2008
3-trial
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
PMID 17353470·Neurology·2007
4-observational
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
PMID 16894068·Arch Gen Psychiatry·2006
4-observational
PET network abnormalities and cognitive decline in patients with mild cognitive impairment.
PMID 16292330·Neuropsychopharmacology·2006
4-observational
A 10-item smell identification scale related to risk for Alzheimer's disease.
PMID 15984022·Ann Neurol·2005
4-observational
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
PMID 15956169·Arch Neurol·2005
4-observational
Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.
PMID 15653941·Am J Geriatr Psychiatry·2005
3-trial
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.
PMID 15325350·Neuroimage·2004
8-other
Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients.
PMID 15013252·J Affect Disord·2004
8-other
Sertraline treatment of elderly patients with depression and cognitive impairment.
PMID 12571820·Int J Geriatr Psychiatry·2003
3-trial
Functional deficits in patients with mild cognitive impairment: prediction of AD.
PMID 11889240·Neurology·2002
8-other
The impact of mild cognitive impairment on functional abilities in the elderly.
PMID 11814398·Curr Psychiatry Rep·2002
6-review
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.
PMID 10964854·Am J Psychiatry·2000
8-other
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
PMID 10920469·Arch Gen Psychiatry·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 617 W END AVE, SUITE 1B
NEW YORK, NY 10024 - Phone
- (212) 579-0339
Quick Facts
- NPI
- 1598892077
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 19
Are you this provider?
Claim Your Profile